Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aravive, Inc. (VSAR) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aravive, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1513818.
Total stock buying since 2014: $31,876,793.
Total stock sales since 2014: $49,330,467.
Total stock option exercises since 2014: $669,510.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 0 | $0 | 4,545,455 | $0 |
| 2021 | 2,000 | $10,655 | 3,245 | $10,448 | 63,694 | $10,013 |
| 2020 | 16,000 | $92,240 | 0 | $0 | 0 | $0 |
| 2019 | 133,333 | $999,997 | 7,563 | $44,376 | 0 | $0 |
| 2018 | 1,108,503 | $2,027,636 | 61,310 | $139,335 | 0 | $0 |
| 2017 | 1,787,735 | $12,555,376 | 3,001,548 | $22,895,201 | 188,166 | $609,666 |
| 2016 | 713,554 | $9,069,439 | 22,782 | $293,614 | 5,000 | $6,324 |
| 2015 | 418,000 | $7,121,450 | 65,752 | $1,294,931 | 24,400 | $30,858 |
| 2014 | 0 | $0 | 1,277,556 | $24,652,562 | 10,000 | $12,649 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-04 | 0 | $0 | 0 | $0 | 4,545,455 | $0 |
| 2021-11 | 0 | $0 | 3,245 | $10,448 | 51,611 | $9,289 |
| 2021-06 | 2,000 | $10,655 | 0 | $0 | 0 | $0 |
| 2021-03 | 0 | $0 | 0 | $0 | 12,083 | $724 |
| 2020-12 | 16,000 | $92,240 | 0 | $0 | 0 | $0 |
| 2019-12 | 133,333 | $999,997 | 0 | $0 | 0 | $0 |
| 2019-10 | 0 | $0 | 4,004 | $27,295 | 0 | $0 |
| 2019-05 | 0 | $0 | 1,192 | $7,283 | 0 | $0 |
| 2019-02 | 0 | $0 | 2,367 | $9,798 | 0 | $0 |
| 2018-12 | 0 | $0 | 16,606 | $62,695 | 0 | $0 |
| 2018-06 | 1,108,503 | $2,027,636 | 755 | $1,735 | 0 | $0 |
| 2018-05 | 0 | $0 | 9,232 | $13,848 | 0 | $0 |
| 2018-04 | 0 | $0 | 4,854 | $7,523 | 0 | $0 |
| 2018-03 | 0 | $0 | 4,345 | $7,603 | 0 | $0 |
| 2018-02 | 0 | $0 | 25,518 | $45,931 | 0 | $0 |
| 2017-12 | 976,467 | $2,115,408 | 0 | $0 | 0 | $0 |
| 2017-10 | 0 | $0 | 4,095 | $10,440 | 0 | $0 |
| 2017-09 | 0 | $0 | 2,130,000 | $7,001,130 | 0 | $0 |
| 2017-06 | 0 | $0 | 2,132 | $34,218 | 0 | $0 |
| 2017-05 | 0 | $0 | 1,263 | $21,976 | 0 | $0 |
| 2017-04 | 0 | $0 | 36,316 | $768,122 | 35,000 | $285,950 |
| 2017-03 | 571,429 | $7,000,005 | 652,041 | $11,973,448 | 0 | $0 |
| 2017-02 | 239,839 | $3,439,963 | 108,934 | $2,107,444 | 99,408 | $222,748 |
| 2017-01 | 0 | $0 | 66,767 | $978,423 | 53,758 | $100,968 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-04-01 | Eshelman Ventures, Llc (Other) | Option Ex | 4,545,455 | .00 | 0 |
| 2021-11-30 | Giaccia Amato (Director) | Sale | 3,245 | 3.22 | 10,448 |
| 2021-11-30 | Giaccia Amato (Director) | Option Ex | 51,611 | .18 | 9,289 |
| 2021-06-29 | Shah Vinay (Chief Financial Officer) | Buy | 1,000 | 5.31 | 5,310 |
| 2021-06-29 | Mcintyre Gail Frances (CEO and President) | Buy | 1,000 | 5.34 | 5,345 |
| 2021-03-19 | Giaccia Amato (Director) | Option Ex | 12,083 | .06 | 724 |
| 2020-12-04 | Shah Vinay (Chief Financial Officer) | Buy | 8,000 | 5.76 | 46,080 |
| 2020-12-04 | Mcintyre Gail Frances (CEO and President) | Buy | 8,000 | 5.77 | 46,160 |
| 2019-12-02 | Akkaraju Srinivas (Director) | Buy | 133,333 | 7.50 | 999,997 |
| 2019-10-07 | Shepard Jay (President and CEO) | Sale | 4,004 | 6.82 | 27,295 |
| 2019-05-10 | Shepard Jay (President and CEO) | Sale | 1,192 | 6.11 | 7,283 |
| 2019-02-01 | Haas Kevin (VP, Finance and PAO) | Sale | 204 | 4.14 | 844 |
| 2019-02-01 | Shepard Jay (President and CEO) | Sale | 2,163 | 4.14 | 8,954 |
| 2018-12-21 | Haas Kevin (VP, Finance and PAO) | Sale | 711 | 3.22 | 2,292 |
| 2018-12-21 | Shepard Jay (President and CEO) | Sale | 3,484 | 3.22 | 11,232 |
| 2018-12-17 | Haas Kevin (VP, Finance and PAO) | Sale | 1,164 | 3.96 | 4,611 |
| 2018-12-17 | Shepard Jay (President and CEO) | Sale | 11,247 | 3.96 | 44,560 |
| 2018-06-15 | Haas Kevin (VP, Finance and PAO) | Sale | 143 | 2.30 | 328 |
| 2018-06-15 | Westberg Paul (SVP and Chief Business Officer) | Sale | 612 | 2.30 | 1,407 |
| 2018-06-13 | Akkaraju Srinivas (Director) | Buy | 53,018 | 2.13 | 112,928 |
| 2018-06-08 | Akkaraju Srinivas (Director) | Buy | 231,580 | 2.00 | 463,160 |
| 2018-06-07 | Akkaraju Srinivas (Director) | Buy | 163,224 | 1.85 | 301,964 |
| 2018-06-06 | Akkaraju Srinivas (Director) | Buy | 660,681 | 1.74 | 1,149,584 |
| 2018-05-22 | Shepard Jay (President and CEO) | Sale | 9,232 | 1.50 | 13,848 |
| 2018-04-24 | Stout Jay S (SVP, Technical Operations) | Sale | 4,854 | 1.55 | 7,523 |
| 2018-03-23 | Woody Tracy M (Chief Commercial Officer) | Sale | 4,345 | 1.75 | 7,603 |
| 2018-02-08 | Haas Kevin (VP, Finance and PAO) | Sale | 1,599 | 1.80 | 2,878 |
| 2018-02-08 | Ward Shane (SVP and General Counsel) | Sale | 4,118 | 1.80 | 7,412 |
| 2018-02-08 | Westberg Paul (SVP and Chief Business Officer) | Sale | 5,355 | 1.80 | 9,639 |
| 2018-02-08 | Shepard Jay (President and CEO) | Sale | 14,446 | 1.80 | 26,002 |
| 2017-12-05 | Akkaraju Srinivas (Director) | Buy | 42,895 | 2.00 | 85,790 |
| 2017-12-04 | Akkaraju Srinivas (Director) | Buy | 513,872 | 2.21 | 1,135,657 |
| 2017-12-01 | Akkaraju Srinivas (Director) | Buy | 419,700 | 2.13 | 893,961 |
| 2017-10-19 | Ward Shane (SVP and General Counsel) | Sale | 776 | 2.55 | 1,978 |
| 2017-10-19 | Westberg Paul (SVP and Chief Business Officer) | Sale | 1,326 | 2.55 | 3,381 |
| 2017-10-19 | Brumm Joshua T (COO and CFO) | Sale | 1,326 | 2.55 | 3,381 |
| 2017-10-19 | Hislop Colin (Chief Medical Officer) | Sale | 667 | 2.55 | 1,700 |
| 2017-09-22 | Edelman Joseph (10% Owner) | Sale | 1,650,000 | 3.18 | 5,248,650 |
| 2017-09-21 | Edelman Joseph (10% Owner) | Sale | 480,000 | 3.65 | 1,752,480 |
| 2017-06-13 | Westberg Paul (SVP and Chief Business Officer) | Sale | 711 | 16.05 | 11,411 |
| 2017-06-13 | Brumm Joshua T (COO and CFO) | Sale | 1,421 | 16.05 | 22,807 |
| 2017-05-16 | Brumm Joshua T (COO and CFO) | Sale | 1,263 | 17.40 | 21,976 |
| 2017-04-19 | Westberg Paul (SVP and Chief Business Officer) | Sale | 1,316 | 19.85 | 26,122 |
| 2017-04-04 | Hislop Colin (Chief Medical Officer) | Sale | 35,000 | 21.20 | 742,000 |
| 2017-04-04 | Hislop Colin (Chief Medical Officer) | Option Ex | 35,000 | 8.17 | 285,950 |
| 2017-03-24 | Akkaraju Srinivas (Director) | Buy | 571,429 | 12.25 | 7,000,005 |
| 2017-03-17 | Malik Shahzad (Director) | Sale | 386,367 | 18.01 | 6,958,469 |
| 2017-03-16 | Malik Shahzad (Director) | Sale | 97,303 | 18.50 | 1,800,105 |
| 2017-03-15 | Ward Shane (SVP and General Counsel) | Sale | 776 | 19.02 | 14,759 |
| 2017-03-15 | Malik Shahzad (Director) | Sale | 103,122 | 19.08 | 1,967,567 |
| 2017-03-14 | Ward Shane (SVP and General Counsel) | Sale | 1,265 | 19.00 | 24,035 |
| 2017-03-14 | Malik Shahzad (Director) | Sale | 46,878 | 19.02 | 891,385 |
| 2017-03-13 | Malik Shahzad (Director) | Sale | 16,330 | 19.42 | 317,128 |
| 2017-02-27 | Westberg Paul (SVP and Chief Business Officer) | Sale | 12,500 | 22.50 | 281,250 |
| 2017-02-27 | Westberg Paul (SVP and Chief Business Officer) | Option Ex | 12,500 | 2.07 | 25,874 |
| 2017-02-27 | Shepard Jay (President and CEO) | Sale | 5,166 | 24.00 | 123,984 |
| 2017-02-27 | Shepard Jay (President and CEO) | Option Ex | 5,166 | 2.53 | 13,069 |
| 2017-02-24 | Brumm Joshua T (COO and CFO) | Sale | 30,000 | 21.31 | 639,300 |
| 2017-02-24 | Brumm Joshua T (COO and CFO) | Option Ex | 30,000 | 2.53 | 75,900 |
| 2017-02-23 | Westberg Paul (SVP and Chief Business Officer) | Sale | 6,590 | 20.00 | 131,800 |
| 2017-02-23 | Westberg Paul (SVP and Chief Business Officer) | Option Ex | 6,590 | 1.61 | 10,609 |
| 2017-02-23 | Shepard Jay (President and CEO) | Sale | 8,000 | 20.00 | 160,000 |
| 2017-02-23 | Shepard Jay (President and CEO) | Option Ex | 8,000 | 2.53 | 20,240 |
| 2017-02-21 | Westberg Paul (SVP and Chief Business Officer) | Sale | 18,410 | 18.75 | 345,187 |
| 2017-02-21 | Westberg Paul (SVP and Chief Business Officer) | Option Ex | 18,410 | 1.61 | 29,640 |
| 2017-02-21 | Shepard Jay (President and CEO) | Sale | 8,000 | 18.50 | 148,000 |
| 2017-02-21 | Shepard Jay (President and CEO) | Option Ex | 8,000 | 2.53 | 20,240 |
| 2017-02-13 | Perceptive Life Sciences Master Fund Ltd | Buy | 59,133 | 15.52 | 917,448 |
| 2017-02-10 | Perceptive Life Sciences Master Fund Ltd | Buy | 34,883 | 14.94 | 521,291 |
| 2017-02-09 | Perceptive Life Sciences Master Fund Ltd | Buy | 41,211 | 14.27 | 587,916 |
| 2017-02-08 | Perceptive Life Sciences Master Fund Ltd | Buy | 104,612 | 13.51 | 1,413,308 |
| 2017-02-03 | Shepard Jay (President and CEO) | Sale | 6,719 | 13.69 | 91,983 |
| 2017-02-02 | Shepard Jay (President and CEO) | Sale | 6,973 | 13.51 | 94,205 |
| 2017-02-02 | Shepard Jay (President and CEO) | Option Ex | 4,166 | 2.53 | 10,539 |
| 2017-02-01 | Shepard Jay (President and CEO) | Sale | 6,576 | 13.95 | 91,735 |
| 2017-02-01 | Shepard Jay (President and CEO) | Option Ex | 6,576 | 2.53 | 16,637 |
| 2017-01-31 | Shepard Jay (President and CEO) | Sale | 10,662 | 13.78 | 146,922 |
| 2017-01-31 | Shepard Jay (President and CEO) | Option Ex | 10,662 | 2.53 | 26,974 |
| 2017-01-30 | Ward Shane (SVP and General Counsel) | Sale | 1,474 | 13.85 | 20,417 |
| 2017-01-30 | Westberg Paul (SVP and Chief Business Officer) | Sale | 1,916 | 13.85 | 26,540 |
| 2017-01-30 | Shepard Jay (President and CEO) | Sale | 17,270 | 13.58 | 234,526 |
| 2017-01-30 | Shepard Jay (President and CEO) | Option Ex | 10,596 | 2.53 | 26,807 |
| 2017-01-30 | Brumm Joshua T (COO and CFO) | Sale | 2,945 | 13.85 | 40,794 |
| 2017-01-11 | Westberg Paul (Sr. VP, Corporate Development) | Sale | 7,931 | 15.24 | 120,868 |
| 2017-01-11 | Westberg Paul (Sr. VP, Corporate Development) | Option Ex | 7,931 | 1.61 | 12,768 |
| 2017-01-10 | Westberg Paul (Sr. VP, Corporate Development) | Sale | 11,213 | 15.66 | 175,595 |
| 2017-01-10 | Westberg Paul (Sr. VP, Corporate Development) | Option Ex | 11,213 | 1.50 | 16,763 |
| 2017-01-09 | Westberg Paul (Sr. VP, Corporate Development) | Sale | 13,356 | 15.93 | 212,761 |
| 2017-01-09 | Westberg Paul (Sr. VP, Corporate Development) | Option Ex | 13,356 | 1.32 | 17,656 |
| 2016-12-30 | Perceptive Life Sciences Master Fund Ltd | Buy | 94,750 | 14.66 | 1,388,845 |
| 2016-12-29 | Perceptive Life Sciences Master Fund Ltd | Buy | 47,375 | 14.37 | 680,589 |
| 2016-12-27 | Westberg Paul (Sr. VP, Corporate Development) | Sale | 361 | 15.85 | 5,721 |
| 2016-12-27 | Brumm Joshua T (Chief Financial Officer) | Sale | 990 | 15.85 | 15,691 |
| 2016-12-16 | Westberg Paul (Sr. VP, Corporate Development) | Sale | 5,000 | 15.00 | 75,000 |
| 2016-12-16 | Westberg Paul (Sr. VP, Corporate Development) | Option Ex | 5,000 | 1.26 | 6,324 |
| 2016-12-08 | Jennings Edmon R (Director) | Sale | 1,500 | 12.96 | 19,432 |
| 2016-12-07 | Brumm Joshua T (Chief Financial Officer) | Sale | 3,021 | 13.25 | 40,028 |
| 2016-10-03 | Akkaraju Srinivas (Director) | Buy | 571,429 | 12.25 | 7,000,005 |
| 2016-08-25 | Varian John (Director) | Sale | 1,600 | 12.97 | 20,755 |
| 2016-08-22 | Shepard Jay (President and CEO) | Sale | 5,442 | 12.88 | 70,092 |
| 2016-06-15 | Westberg Paul (Sr. VP, Business Development) | Sale | 725 | 10.63 | 7,706 |
| 2016-06-15 | Brumm Joshua T (Chief Financial Officer) | Sale | 1,448 | 10.63 | 15,392 |
| 2016-05-20 | Brumm Joshua T (Chief Financial Officer) | Sale | 1,265 | 7.87 | 9,955 |
| 2016-04-21 | Westberg Paul (Sr. VP, Business Development) | Sale | 1,430 | 9.68 | 13,842 |
| 2015-12-30 | Westberg Paul (Sr. VP, Business Development) | Sale | 362 | 12.44 | 4,501 |
| 2015-12-30 | Brumm Joshua T (Chief Financial Officer) | Sale | 990 | 12.44 | 12,311 |
| 2015-11-12 | Brumm Joshua T (Chief Financial Officer) | Buy | 2,500 | 9.99 | 24,975 |
| 2015-11-11 | Greer R Scott (Director) | Buy | 10,000 | 10.16 | 101,600 |
| 2015-08-04 | Westberg Paul (Sr. VP, Business Development) | Sale | 2,400 | 18.39 | 44,136 |
| 2015-08-04 | Westberg Paul (Sr. VP, Business Development) | Option Ex | 2,400 | 1.26 | 3,035 |
| 2015-07-06 | Westberg Paul (Sr. VP, Business Development) | Sale | 2,400 | 15.00 | 36,000 |
| 2015-07-06 | Westberg Paul (Sr. VP, Business Development) | Option Ex | 2,400 | 1.26 | 3,035 |
| 2015-06-03 | Westberg Paul (Sr. VP, Business Development) | Sale | 2,400 | 16.73 | 40,142 |
| 2015-06-03 | Westberg Paul (Sr. VP, Business Development) | Option Ex | 2,400 | 1.26 | 3,035 |
| 2015-05-04 | Westberg Paul (Sr. VP, Business Development) | Sale | 2,400 | 17.47 | 41,930 |
| 2015-05-04 | Westberg Paul (Sr. VP, Business Development) | Option Ex | 2,400 | 1.26 | 3,035 |
| 2015-04-14 | Cleland Jeffrey L (President and CEO) | Sale | 8,000 | 20.13 | 161,040 |
| 2015-04-06 | Westberg Paul (Sr. VP, Business Development) | Sale | 2,400 | 17.49 | 41,971 |
| 2015-04-06 | Westberg Paul (Sr. VP, Business Development) | Option Ex | 2,400 | 1.26 | 3,035 |
| 2015-03-23 | Cleland Jeffrey L (President and CEO) | Sale | 4,000 | 20.26 | 81,028 |
| 2015-03-20 | Cleland Jeffrey L (President and CEO) | Sale | 740 | 20.07 | 14,849 |
| 2015-03-19 | Cleland Jeffrey L (President and CEO) | Sale | 1,315 | 20.01 | 26,311 |
| 2015-03-18 | Cleland Jeffrey L (President and CEO) | Sale | 1,124 | 20.03 | 22,514 |
| 2015-03-17 | Cleland Jeffrey L (President and CEO) | Sale | 738 | 20.09 | 14,827 |
| 2015-03-16 | Cleland Jeffrey L (President and CEO) | Sale | 83 | 20.02 | 1,661 |
| 2015-03-10 | Cleland Jeffrey L (President and CEO) | Sale | 2,537 | 20.30 | 51,501 |
| 2015-03-09 | Cleland Jeffrey L (President and CEO) | Sale | 1,463 | 20.10 | 29,410 |
| 2015-03-03 | Westberg Paul (Sr. VP, Business Development) | Sale | 2,400 | 20.03 | 48,069 |
| 2015-03-03 | Westberg Paul (Sr. VP, Business Development) | Option Ex | 2,400 | 1.26 | 3,035 |
| 2015-03-03 | Cleland Jeffrey L (President and CEO) | Sale | 1,129 | 20.07 | 22,657 |
| 2015-03-02 | Cleland Jeffrey L (President and CEO) | Sale | 2,871 | 20.11 | 57,747 |
| 2015-02-25 | Cleland Jeffrey L (President and CEO) | Sale | 8,000 | 20.25 | 161,976 |
| 2015-02-03 | Westberg Paul (Sr. VP, Business Development) | Sale | 5,000 | 17.72 | 88,600 |
| 2015-02-03 | Westberg Paul (Sr. VP, Business Development) | Option Ex | 5,000 | 1.26 | 6,324 |
| 2015-01-27 | Sun Anthony Y | Buy | 145,000 | 17.25 | 2,501,250 |
| 2015-01-27 | Greer R Scott (Director) | Buy | 5,500 | 17.25 | 94,875 |
| 2015-01-27 | Schiff Andrew N | Buy | 145,000 | 17.25 | 2,501,250 |
| 2015-01-22 | Advent Life Sciences Fund I Lp (Other) | Buy | 55,000 | 17.25 | 948,750 |
| 2015-01-22 | Malik Shahzad (Director) | Buy | 55,000 | 17.25 | 948,750 |
| 2015-01-12 | Cleland Jeffrey L (President and CEO) | Sale | 4,000 | 22.86 | 91,420 |
| 2015-01-05 | Westberg Paul (Sr. VP, Business Development) | Sale | 5,000 | 22.76 | 113,810 |
| 2015-01-05 | Westberg Paul (Sr. VP, Business Development) | Option Ex | 5,000 | 1.26 | 6,324 |
| 2015-01-05 | Cleland Jeffrey L (President and CEO) | Sale | 4,000 | 21.63 | 86,520 |
| 2014-12-29 | Cleland Jeffrey L (President and CEO) | Sale | 4,000 | 22.11 | 88,420 |
| 2014-12-22 | Cleland Jeffrey L (President and CEO) | Sale | 7,980 | 20.95 | 167,149 |
| 2014-12-19 | Cleland Jeffrey L (President and CEO) | Sale | 20 | 20.00 | 400 |
| 2014-12-18 | Ratcliffe Liam (10% Owner) | Sale | 150,000 | 19.01 | 2,851,800 |
| 2014-12-12 | Westberg Paul (Sr. VP, Business Development) | Sale | 3,054 | 18.65 | 56,969 |
| 2014-12-12 | Westberg Paul (Sr. VP, Business Development) | Option Ex | 3,054 | 1.26 | 3,863 |
| 2014-12-11 | Westberg Paul (Sr. VP, Business Development) | Sale | 6,946 | 18.51 | 128,570 |
| 2014-12-11 | Westberg Paul (Sr. VP, Business Development) | Option Ex | 6,946 | 1.26 | 8,786 |
| 2014-11-24 | Yucca (jersey) Slp | Sale | 17,207 | 18.02 | 310,001 |
| 2014-11-21 | Index Ventures Iv Parallel Entrepreneur Fund (jersey) Lp | Sale | 26,793 | 18.04 | 483,318 |
| 2014-11-20 | Yucca (jersey) Slp | Sale | 9,000 | 18.32 | 164,889 |
| 2014-11-18 | Yucca (jersey) Slp | Sale | 191,362 | 19.38 | 3,708,978 |
| 2014-11-13 | Yucca (jersey) Slp | Sale | 12,438 | 19.43 | 241,695 |
| 2014-11-12 | Yucca (jersey) Slp | Sale | 36,200 | 19.42 | 703,040 |
| 2014-11-11 | Ratcliffe Liam (10% Owner) | Sale | 800,000 | 19.37 | 15,496,000 |
| 2014-09-29 | Ratcliffe Liam (10% Owner) | Sale | 12,556 | 20.02 | 251,333 |
Insider trading activities including stock purchases, stock sales, and option exercises of VSAR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aravive, Inc. (symbol VSAR, CIK number 1513818) see the Securities and Exchange Commission (SEC) website.